Enzo Biochem (ENZ) Posts Narrower than Expected Q3 Loss
Tweet
Share
E-mailGet Alerts ENZ Hot Sheet
Price: $0.31 --0%
Financial Fact:
Research and development: 822K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Research and development: 822K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Enzo Biochem, Inc. (NYSE: ENZ) reported Q3 loss of ($0.05), $0.06 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $25.8 million versus the consensus estimate of $24.77 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance
- Ciena (CIEN) Tops Q3 EPS by 39c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
